SEC Company Response from Pyxis Oncology, (PYXS) — Dec 8, 2025
Pyxis Oncology, Inc.
Date: Dec. 8, 2025 · CIK: 0001782223 · Accession: 0001437749-25-037150
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-291801
Letter
pyxs20251208_corresp.htm
December 8, 2025
Via EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549-3720
Attention: Lauren Hamill
Re:
Acceleration Request for Pyxis Oncology, Inc.
Registration Statement on Form S-3 (File No. 333-291801)
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, Pyxis Oncology, Inc. (the “ Company ”), hereby requests that the effective date of the Company’s Registration Statement on Form S-3, Registration Number 333-291801 (the “ Registration Statement ”) be accelerated so that the Company’s Registration Statement will become effective at 5:00 P.M., Eastern Time or as soon thereafter as practicable, on December 9, 2025, or at such later time as the Company or its counsel may orally request via telephone call to the staff of the Division of Corporation Finance of the U.S. Securities and Exchange Commission.
We would appreciate it if, as soon as the Registration Statement is declared effective, you would so inform Istvan A. Hajdu of Sidley Austin LLP at (212) 839-5651.
[Signature Page Immediately Follows]
Very truly yours,
/s/ Jitendra Wadhane
Show Raw Text
CORRESP 1 filename1.htm pyxs20251208_corresp.htm December 8, 2025 Via EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549-3720 Attention: Lauren Hamill Re: Acceleration Request for Pyxis Oncology, Inc. Registration Statement on Form S-3 (File No. 333-291801) Ladies and Gentlemen: Pursuant to Rule 461 under the Securities Act of 1933, as amended, Pyxis Oncology, Inc. (the “ Company ”), hereby requests that the effective date of the Company’s Registration Statement on Form S-3, Registration Number 333-291801 (the “ Registration Statement ”) be accelerated so that the Company’s Registration Statement will become effective at 5:00 P.M., Eastern Time or as soon thereafter as practicable, on December 9, 2025, or at such later time as the Company or its counsel may orally request via telephone call to the staff of the Division of Corporation Finance of the U.S. Securities and Exchange Commission. We would appreciate it if, as soon as the Registration Statement is declared effective, you would so inform Istvan A. Hajdu of Sidley Austin LLP at (212) 839-5651. [Signature Page Immediately Follows] Very truly yours, /s/ Jitendra Wadhane Jitendra Wadhane Principal Financial and Accounting Officer cc: Lara Sullivan, Pyxis Oncology, Inc. Asher Rubin, Sidley Austin LLP Istvan A. Hajdu, Sidley Austin LLP